Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms
Top Cited Papers
Open Access
- 6 April 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in BioMetals
- Vol. 29 (3), 365-376
- https://doi.org/10.1007/s10534-016-9931-7
Abstract
Gadolinium chelates are widely used as contrast media for magnetic resonance imaging. The approved gadolinium-based contrast agents (GBCAs) have historically been considered safe and well tolerated when used at recommended dosing levels. However, for nearly a decade, an association between GBCA administration and the development of nephrogenic systemic fibrosis (NSF) has been recognized in patients with severe renal impairment. This has led to modifications in clinical practices aimed at reducing the potential and incidence of NSF development. Newer reports have emerged regarding the accumulation of gadolinium in various tissues of patients who do not have renal impairment, including bone, brain, and kidneys. Despite the observations of gadolinium accumulation in tissues regardless of renal function, very limited clinical data regarding the potential for and mechanisms of toxicity is available. This significant gap in knowledge warrants retrospective cohort study efforts, as well as prospective studies that involve gadolinium ion (Gd3+) testing in patients exposed to GBCA. This review examines the potential biochemical and molecular basis of gadolinium toxicity, possible clinical significance of gadolinium tissue retention and accumulation, and methods that can limit gadolinium body burden.Keywords
This publication has 59 references indexed in Scilit:
- N-Acetylcysteine Protects Rats with Chronic Renal Failure from Gadolinium-Chelate NephrotoxicityPLOS ONE, 2012
- Gadolinium‐induced oxidative stress triggers endoplasmic reticulum stress in rat cortical neuronsJournal of Neurochemistry, 2011
- NFκB activation and stimulation of chemokine production in normal human macrophages by the gadolinium-based magnetic resonance contrast agent Omniscan: possible role in the pathogenesis of nephrogenic systemic fibrosisAnnals Of The Rheumatic Diseases, 2010
- Chelation in Metal IntoxicationInternational Journal of Environmental Research and Public Health, 2010
- Primer on gadolinium chemistryJournal of Magnetic Resonance Imaging, 2009
- Incorporation of excess gadolinium into human bone from medical contrast agentsMetallomics, 2009
- Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical reviewBioMetals, 2008
- A Preclinical Study to Investigate the Development of Nephrogenic Systemic Fibrosis: A Possible Role for Gadolinium-Based Contrast MediaInvestigative Radiology, 2008
- Long‐term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium‐enhanced MRI scans: case report and implicationsContrast Media & Molecular Imaging, 2007
- Cardiac arrest caused by IV gadopentetate dimeglumine.American Journal of Roentgenology, 1999